NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations Dive in today!

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Search

Contact Us

Search

Contact Us

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Our Company

About Us
Our History
Mission & Values
Executive Leadership

Locations

Global Facilities Network
Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba
Yokohama
Longmont

Policies

Environment, Health & Safety
Group Privacy Policies

Offerings

Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA

Services

Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish Services

Specialized Platforms & Programs

AGCellerate™ mAb & LVV Programs
ProntoLVV™ Lentiviral Vector Platform
BravoAAV™ Adeno-Associated Vector Platform
Proveo™ ADC Program
CMC Jumpstart™ Program

News & Blogs

Press Releases
Biopharma Thought Leadership Blog
Events & Conferences

Resources

Research & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit

Fact Sheet Quick Links

Global cGMP Manufacturing (PDF)
CHEF1^TM Expression Technology (PDF)
Mammalian Capabilities (PDF)
Microbial Capabilities (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)

Join Us

Career Opportunities

What Drives Us

Life at a CDMO
Diversity, Equity and Inclusion

Meet Our Teams

Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

1 min read

AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site

January 21, 2021 at 10:00 AM

Press Release

Read press release

3 min read

AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics’ Newly Approved Libmeldy™

January 4, 2021 at 6:30 AM

Press Release

Read press release

Our Mission

To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.

Links

About Us
Our Services
Locations
Careers
Contact Us
Media Kit

News

Featured Blog Image

AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need

Today, we announced we will commence cell therapy process development and clinical manufacturing...

Events

Featured Blog Image

JSGCT, July 23-25

Date: July 23-25, 2025

Location: Palace Side Building, Tokyo, Japan

Event Website: ...

Legal & Compliance

© 2025 AGC Biologics. All Rights Reserved.

AGC Inc. Group